Evidence check: CYP1A2 in the context of longevity

The provided context lacks specific information on CYP1A2 in relation to longevity. CYP1A2 is a cytochrome P450 enzyme primarily involved in caffeine and drug metabolism. Some research suggests a potential role in detoxifying environmental toxins and endogenous metabolites, which could theoretically influence aging processes. However, robust human studies directly linking CYP1A2 variants to lifespan are absent. The evidence is limited to mechanistic plausibility and associations with caffeine intake, which itself is linked to cardiovascular and neurodegenerative risks. Without concrete data from the given knowledge base, a well-founded statement on longevity is not possible. Consumers of DNA tests should be aware that the clinical relevance of CYP1A2 polymorphisms for life expectancy is currently unestablished. Interpretation of such results requires caution and should not drive lifestyle or supplementation decisions.